patent.fyi
Applications  /  US 2026/0355226
United States Patent Application Publication

US 2026/0355226 A1

Published
Nov 12, 2026
Filed
Mar 10, 2026
Earliest date on the face
Oct 11, 2018
Classification
A61K 31/7024
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

No entries.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Timed dosing in a mineralization assay

A laboratory perfusion chamber holds collagen disks in a recirculating calcium and phosphate solution. A metering pump adds myo-inositol hexaphosphate to the reservoir on three nonconsecutive days each week, and a matched chamber receives the same volume of vehicle. A technician rinses the disks at the end of the run and measures deposited calcium in acid extracts.

Component substitution

Inositol pentakisphosphate in a flow assay

Myo-inositol 1,3,4,5,6-pentakisphosphate replaces myo-inositol hexaphosphate in a calcium phosphate deposition assay. Paired peristaltic pump channels deliver equal molar pulses of the two compounds to separate chambers containing collagen coupons. Both channels use the same buffer, flow rate, and pulse schedule, and an endpoint calcium assay measures deposition on each coupon.

Parameter or scale variation

Split pulses in a perfusion chamber

A 10 mL recirculating perfusion chamber receives a total of 200 microliters of myo-inositol hexaphosphate stock on each of three dosing days per week. One channel receives a single 200 microliter pulse, and a parallel channel receives two 100 microliter pulses six hours apart. Both channels use the same stock concentration and flow rate, and calcium deposition on removable coupons is measured after 28 days.

Combination with existing systems

Dialysis scheduling with infusion pump records

A dialysis scheduling system displays an ordered myo-inositol hexaphosphate infusion alongside each of three weekly dialysis appointments. The infusion record stores the prescribed dose in milligrams per kilogram, the verified dosing weight, and the solution concentration used to calculate the infusion volume. A clinician confirms the order at each visit, and the infusion pump sends start time, stop time, and delivered volume to the medication record.

Serial radiography with infusion event records

A digital radiography workstation imports dated infusion records and groups images by anatomical site. Each imaging session uses a positioning fixture and a mineral reference step wedge in the image field. The workstation aligns follow-up images to baseline landmarks, measures projected calcified area within a fixed region, and plots the measurements against recorded infusion dates.

Automated or data-driven variant

Automated stock dosing by reservoir mass

A load cell supports the reservoir of a benchtop mineralization loop, and a controller operates a syringe pump containing myo-inositol hexaphosphate stock. At each scheduled dosing event, the controller converts the target stock volume to a mass increment using the measured stock density. It pauses recirculation, tares the load cell, dispenses stock until the target mass increment is reached, and resumes circulation. The controller logs the measured mass increment and stops the pump if the reading fails to increase within a preset time.

Cite aspatent.fyi, US 2026/0355226 A1, claim 1, first published 2026-11-19T09:44:02-05:00, https://patent.fyi/US20260355226/, SHA-256 40147fe33f036dbf6d8629e7c76baea74227f4b0463a48e4cc22808fa5b64756
First published
Permanent addresshttps://patent.fyi/US20260355226/
Content fingerprint (SHA-256)40147fe33f036dbf6d8629e7c76baea74227f4b0463a48e4cc22808fa5b64756
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi